Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Index benchmarks provide a transparent yardstick for performance, helping investors gauge risk-adjusted returns and make informed choices.
27,627 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Bitcoin briefly dipped below $65,000 on Sunday as tariff headlines surged, but the crypto recovered Monday amid a bro...
The SEC submitted interpretive guidance to OIRA to clarify how federal securities laws could apply to crypto assets. ...
The 2026 Farm Bill quietly expands AI and precision-agriculture subsidies while letting private tech firms set standa...
In 2026, a disciplined trio of growth ETFs offers a clear path to long-term wealth through earnings-driven expansion,...
A California court has ruled that addictive features in social apps can harm mental health, a verdict with potential ...
Tesla stock jumps about 19% in the past month, renewing the old Sell in May debate as summer trading looms and moment...
Oppenheimer boosts its Palo Alto Networks price target to $275 citing strong demand for the Idira identity security p...
Bond yields jumped to the mid-4% range on the benchmark 10-year, nudging investors to re-evaluate risk. Research Affi...
Goldman Sachs marks Nvidia and Micron as the leading AI winners ahead of the upcoming earnings season, triggering fre...
NIO posted a 62% year-over-year jump in May deliveries, sending stock higher as it rolls out new models. Tesla edged ...
A once-prolific $1,000 strategy beat the market story has turned into a cautionary tale. New investors face sharp los...